Otezla 30 MG tablet 60S

Ended Awarded

Contract number
SPE2DR26F8ZJC
Awardee
Awarding agency
Obligated
$21,157

Award facts

Contract value 100% obligated
$21,156.58 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,156.58 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 million global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across diverse therapeutic domains, including specialty medications, vaccines, and medical supplies. The DLA Troop Support Medical IDC under which this delivery order falls represents a flexible contracting vehicle designed to support military healthcare operations globally, with the DLA planning additional Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.

Quick answers

Who was awarded contract SPE2DR26F8ZJC?

SPE2DR26F8ZJC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.

How much is contract SPE2DR26F8ZJC worth?

The government has obligated $21,157 on SPE2DR26F8ZJC.

Is contract SPE2DR26F8ZJC an order under another contract?

Yes. SPE2DR26F8ZJC is a delivery order under SPE2DR25D1017, an indefinite delivery contract.

Was contract SPE2DR26F8ZJC competed?

The extent of competition for SPE2DR26F8ZJC was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award